A significant decrease in CD4 and CD8 T cells, as well as MAITs, upon FTY720 administration, as shown in Fig. 4, suggested that CCR7+ MAITs could be present in MS, probably during the acute relapse stage or in the secondary lymphoid organs, which we did not examine in this study. The gene discussed is CCR7; the disease is myeloid sarcoma.